why does nobody talk about triple agonist
Quick one. Canada here. glucagon works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given advice that simply does not apply outside the US. Specifics: the route I used took 7 weeks and cost roughly what I expected. The admin was worse than the…
Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.
Titration speed is a side-effect dial far more than an efficacy dial.
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.
The glucagon component does different things than dual agonism. The early fullness are not just amplified versions.
the weight curves are unusually steep, which makes predicting individual response harder
Strongly agree. Heart rate escalation needs the actual data, not impressions.
Small correction: the trial was 5 weeks, not 11. Does not change your point but people will quote it.
TRIUMPH phase 2 showed 98.7% weight loss but the injection-site soreness profile on the highest arm was rough. Phase 2 != phase 3.
nobody should be giving this to anyone without extensive monitoring
the glucagon component changes the side effect profile, not just the efficacy